Avoiding Pitfalls in Plain Language Summaries of Clinical Trial Results

Speaker(s): Tatyana Wanderer, Behtash Bahador
Date: May 24, 2017
Time: 11 am ET
Duration: 1 hr.

In recent years, pharmaceutical companies have become increasingly aware of the regulatory and ethical mandates to develop and disseminate plain language summaries of clinical trial results. However, awareness alone doesn’t confer the ability to develop scientifically accurate, non-promotional, and easy to understand plain language summaries.

When the results of your clinical trials become available, will you be ready to communicate them to patients in a timely manner? Do you have the experience and expertise needed to comply with the latest guidance from regulatory bodies and plain language standards?

CISCRP and Synchrogenix have partnered to offer a program to meet upcoming reporting requirements, increase public transparency and trust, and engage patient communities. In this webinar, Tatyana Wanderer and Behtash Bahador will provide insights and recommendations gained from working with leading sponsors on portfolio-wide implementation and pilot programs to create plain language summaries of clinical trial results. Whether you’re just starting program planning or simply need help developing compliant and patient-friendly summaries of clinical trial results, by attending this webinar, you’ll gain keys insights on what it takes to develop a plain language summary program that meets all your needs.

About Our Speakers

Tatyana Wanderer, PhD, is the Director of Strategic Partnerships and Alliances at Synchrogenix, a Certara company. She has experience in clinical writing and project management of a variety of ICH-compliant documents, with expertise in documentation related to rare disease indications.

Behtash Bahador is a Senior Project Manager for the non-profit Center for Information and Study on Clinical Research Participation (CISCRP). With a background in health communication, Behtash leads global implementation of programs for communicating clinical trial results in plain language for a wide range of industry sponsors. He works directly with sponsors to align best practices in patient education and health communication with regulatory and industry guidelines.

Learn More